Eunice Kennedy Shriver National Institute of Child Health and Human Development to Grant Exclusive Patent License to EnZeta Immunotherapies

Summary

The Eunice Kennedy Shriver National Institute of Child Health and Human Development is considering granting an exclusive patent license to EnZeta Immunotherapies, Inc. for its inventions related to enhanced tumor reactivity of T cells.